Metrics as of 10/13/2026, 06:45 PM (Berlin time), refresh in progress.
Alcon Inc.
Alcon Inc. is a global eye care enterprise dedicated to the research, development, manufacturing, and distribution of a comprehensive range of vision products for both eye care professionals and their patients worldwide. The company operates through two primary divisions. Its Surgical segment equips ophthalmic…
Company description based on the data provider's company data, AI-assisted, created on 15/10/2026. Not investment advice.
1D
-0.7%
1W
+3.0%
1M
-0.7%
6M
-14.3%
YTD
-13.5%
1Y
-9.1%
2Y
-33.7%
5Y
-24.5%
10Y
–
Next earnings date
10/11/2026 (in 24 days)
Volatility around earnings
~73% stronger price swings than usual
0
STRONG BUY
14
BUY
7
HOLD
2
SELL
0
STRONG SELL
23
TOTAL · Buy
As of: 12/10/2026
P/E
50.91
P/B
1.49
EV/EBITDA
12.52
RETURN ON EQUITY
0.0%
NET MARGIN
0.0%
DEBT/EQUITY
0.25
DIVIDEND YIELD
0.5%
AS OF
30/06/2026
FREE FLOAT
99.7%
FLOAT SHARES
486,144,237
AVG. DAILY VOLUME (30D)
969,126
Alcon Inc. is a company in the Healthcare sector, Medical - Specialties industry, headquartered in Switzerland.
The CEO is David J. Endicott, the company employs around 25,000 people.
The IPO was on 08/04/2019; the stock trades on SIX under the ticker ALC.SW.
23 analysts rate the stock, the consensus is Buy (as of 12/10/2026).
This is an external assessment, not a statement by Market Jury.
The next earnings date is 10/11/2026.
Around past earnings, price swings were roughly 73% stronger than usual.
Yes. The last dividend was CHF 0.28 per share, ex-date 05/05/2026, paid on 07/05/2026.
The dividend yield is 0.5% (as of 30/06/2026).
Comparable stocks include STERIS, QuidelOrtho, Mesa Laboratories, 908 Devices, Trinity Biotech, Roche Holding, BeOne Medicines and Sandoz Group.
Clicking "Analyze stock" lets five strategies assess Alcon against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.